GGrantIndex
Sort

23,748 grants matching melanoma

Nucleotide Excision Repair in Cutaneous Melanoma

$133,810
Massachusetts General Hospital · K08 · FY2004 · CA

Nucleotide Excision Repair in Cutaneous Melanoma

$133,810
Hensin Tsao · Massachusetts General Hospital · K08 · FY2006 · CA

Nucleotide Excision Repair in Cutaneous Melanoma

$133,810
Massachusetts General Hospital · K08 · FY2003 · CA

SOUTHWEST ONCOLOGY GROUP STUDY

$133,768
Henry Ford Health System · U10 · FY2001 · CA

CANCER AND LEUKEMIA GROUP B

$133,730
Weill Medical College Of Cornell Univ · U10 · FY2000 · CA

PLANNING AND EVALUATION (Core 001)

$133,717
Nancy E Davidson · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · CA

Cardiovascular Diseases among Patients with Cancer and Patients living with HIV

$133,685
Tomas G Neilan · Massachusetts General Hospital · K24 · FY2025 · HL

Multiple Antigen-Engineered DC Immunication & IFNa Boost for Metastatic Melanoma

$133,619
Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P50 · FY2008 · CA

Tissue, Pathology and Bioinformatics

$133,594
Jane L Messina · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2015 · CA

Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)

$133,520
James R. Heath · Institute For Systems Biology · U54 · FY2024 · CA

PLANNING AND EVALUATION (Core 001)

$133,305
Nancy E Davidson · University Of Pittsburgh At Pittsburgh · P30 · FY2016 · CA

Genetic Mechanisms of Immunity and Inflammation in Melonoma Progression

$133,193
Jeffrey E Lee · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA

MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM

$133,175
Michael Alan Schwartz · Mount Sinai Medical Center (Miami Beach) · U10 · FY2014 · CA

Credentialing murine models for glioblastoma preclinical drug development

$133,154
Christopher Ryan Miller · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA

Targets for Anti-Tumor Immunity in Melanoma

$133,043
University Of Virginia Charlottesville · K08 · FY2003 · CA

Core E: Biostatistics Core

$132,988
Meenhard Herlyn · Wistar Institute · P01 · FY2015 · CA

Administrative Core

$132,913
Eva Hernando · New York University School Of Medicine · U54 · FY2024 · CA

Core E: Biostatistics Core

$132,899
Meenhard Herlyn · Wistar Institute · P01 · FY2016 · CA

Characterizing and Regulating Tumor-induced Regulatory T Cells

$132,885
Christian H Poehlein · Providence Portland Medical Center · K22 · FY2010 · CA

Core E: Biostatistics Core

$132,881
Meenhard Herlyn · Wistar Institute · P01 · FY2017 · CA

Role of COX-2 in UVB-induced beta-catenin signaling in keratinocytes

$132,845
Jill C. Pelling · Northwestern University At Chicago · R21 · FY2011 · AR

Enhanced Development of the Xiphophorus Model System R24-OD-011120

$132,820
Ronald Walter · Texas State University · R24 · FY2018 · OD

Innate immunity in dermal fibrosis and systemic sclerosis

$132,795
Robert A Lafyatis · Boston University Medical Campus · R01 · FY2015 · AR

Adoptive Cell Therapy with Rejuvenated Antigen-Specific T Cells

$132,754
Fumito Ito · Roswell Park Cancer Institute Corp · K08 · FY2015 · CA

Eastern Cooperative Oncology Group

$132,658
Beth Israel Deaconess Medical Center · U10 · FY2004 · CA